GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cordlife Group Ltd (SGX:P8A) » Definitions » Days Sales Outstanding

Cordlife Group (SGX:P8A) Days Sales Outstanding : 162.15 (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Cordlife Group Days Sales Outstanding?

Cordlife Group's average Accounts Receivable for the six months ended in Dec. 2023 was S$24.36 Mil. Cordlife Group's Revenue for the six months ended in Dec. 2023 was S$27.42 Mil. Hence, Cordlife Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 162.15.

The historical rank and industry rank for Cordlife Group's Days Sales Outstanding or its related term are showing as below:

SGX:P8A' s Days Sales Outstanding Range Over the Past 10 Years
Min: 89.2   Med: 139.37   Max: 163.57
Current: 161.98

During the past 12 years, Cordlife Group's highest Days Sales Outstanding was 163.57. The lowest was 89.20. And the median was 139.37.

SGX:P8A's Days Sales Outstanding is ranked worse than
78.8% of 217 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.88 vs SGX:P8A: 161.98

Cordlife Group's Days Sales Outstanding increased from Dec. 2022 (154.27) to Dec. 2023 (162.15).


Cordlife Group Days Sales Outstanding Historical Data

The historical data trend for Cordlife Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cordlife Group Days Sales Outstanding Chart

Cordlife Group Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 142.07 146.76 152.50 163.57 157.67

Cordlife Group Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 146.87 164.77 154.27 166.06 162.15

Competitive Comparison of Cordlife Group's Days Sales Outstanding

For the Diagnostics & Research subindustry, Cordlife Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cordlife Group's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Cordlife Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cordlife Group's Days Sales Outstanding falls into.



Cordlife Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cordlife Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (25.475 + 22.672) / 2 ) / 55.73*365
=24.0735 / 55.73*365
=157.67

Cordlife Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (26.049 + 22.672) / 2 ) / 27.417*365 / 2
=24.3605 / 27.417*365 / 2
=162.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cordlife Group  (SGX:P8A) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Cordlife Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cordlife Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Cordlife Group (SGX:P8A) Business Description

Traded in Other Exchanges
Address
1 Yishun Industrial Street 1, Number 06-01/09, A'Posh Bizhub, Singapore, SGP, 768160
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.

Cordlife Group (SGX:P8A) Headlines

No Headlines